Hair cloning and injection of dermalpapilla cells are discussed, with skepticism about their availability by 2023. Users mention Minoxidil, finasteride, and hair transplants as current treatments.
Epibiotech will offer off-the-shelf allogeneic hair multiplication treatment in South Korea, using dermalpapilla cells from donors to grow hair in balding areas. This method is cheaper and less invasive than traditional hair transplants.
A study that outlines the full model for androgenic alopecia (AGA) which links DHT to cellular senescence in dermalpapilla cells, and suggests black chokeberry as a source of cyanidin 3-O-arabinoside polyphenol with potential anti-oxidant properties that could reverse this process. The post encourages reaching out to experts in anti-aging and longevity to research treatments involving the polyphenol.
NMN shows promise in promoting hair growth by reducing oxidative stress and weakening androgens. It may be a beneficial addition to hair loss treatments like Minoxidil and Finasteride.
HairClone is developing cell replacement treatments to rejuvenate and generate hair follicles, and has launched a crowdfunding campaign. A user expressed skepticism about the need for crowdfunding.